Loading...
XJPX4109
Market cap346mUSD
Jan 23, Last price  
4,430.00JPY
1D
1.12%
1Q
1.12%
Jan 2017
44.00%
Name

Stella Chemifa Corp

Chart & Performance

D1W1MN
XJPX:4109 chart
P/E
28.92
P/S
1.75
EPS
153.21
Div Yield, %
3.98%
Shrs. gr., 5y
-1.42%
Rev. gr., 5y
-4.53%
Revenues
30.45b
-13.95%
17,576,000,00019,954,000,00021,917,000,00025,496,000,00025,561,000,00023,572,000,00028,320,000,00029,271,000,00028,118,000,00028,447,000,00028,341,000,00027,509,000,00029,850,000,00033,622,000,00038,384,000,00033,729,000,00032,893,000,00037,296,000,00035,382,000,00030,446,000,000
Net income
1.85b
-19.08%
1,055,000,0001,435,000,0001,805,000,0001,757,000,000359,000,0002,291,000,0001,812,000,000943,000,0001,941,000,000765,000,0001,322,000,0001,323,000,0002,824,000,0001,274,000,0002,350,000,0001,924,000,0002,959,000,0005,364,000,0002,280,000,0001,845,000,000
CFO
6.54b
+16.12%
3,120,000,0003,030,000,0003,535,000,0003,607,000,0003,941,000,0005,954,000,0003,664,000,0002,230,000,0005,087,000,0003,633,000,0004,947,000,0005,228,000,0005,341,000,000937,000,0007,345,000,0005,036,000,0007,352,000,0005,403,000,0005,634,000,0006,542,000,000
Dividend
Mar 28, 20250 JPY/sh

Profile

Stella Chemifa Corporation manufactures and sells inorganic fluorine compounds in Japan and internationally. It offers hydrofluoric acid, buffered hydrofluoric acid, and etching solutions used in semiconductors, liquid crystal products, and solar batteries; calcium, aluminum, lithium, strontium, barium, magnesium, zinc, and lead fluoride used in optical materials; and lithium hexafluorophosphate for batteries. The company also provides boron trifluoride, boron trifluoride diethyl ether, boron trifluoride dimethyl ether, boron trifluoride n-butyl ether, boron trifluoride tetrahydrofuran, boron trifluoride phenol, boron trifluoride monoethyl amine, boron trifluoride piperidine, and triethylamine 3HF used in reactive catalysts; and anhydrous hydrofluoric acid and 55% hydrofluoric acid used in surface treatment and alternatives for CFCs. In addition, it offers potassium fluoroborate and boric acid for nuclear energy applications; tin fluoride (II) USP used in GMP-compliant products; and other products, such as fluorosilicic acid, potassium fluorosilicate, ammonium fluorosilicate, fluoroboric acid, tin fluoroborate, copper fluoroborate, lead fluoroborate, zinc fluoroborate, sodium fluoroborate, potassium fluoroborate, ammonium hydrogenfluoride, sodium fluoride, potassium fluoride, ammonium fluoride, potassium hexafluorozirconate, potassium hexafluorotitanate, refined calcium fluoride, and potassium hexafluorophosphate. Further, the company transports a range of special chemical substances, high-pressure gas, hazardous materials, and related products. Additionally, it develops Boron Neutron Capture therapy for the treatment of cancer. The company was formerly known as Hashimoto Chemical Corporation and changed its name to Stella Chemifa Corporation in 1997. Stella Chemifa Corporation was founded in 1916 and is headquartered in Osaka, Japan.
URL
https://www.stella-chemifa.co.jp/
IPO date
Oct 01, 1999
Employees
727
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
30,446,000
-13.95%
35,382,000
-5.13%
37,296,000
13.39%
Cost of revenue
27,723,000
31,868,000
29,138,000
Unusual Expense (Income)
NOPBT
2,723,000
3,514,000
8,158,000
NOPBT Margin
8.94%
9.93%
21.87%
Operating Taxes
777,000
1,383,000
1,814,000
Tax Rate
28.53%
39.36%
22.24%
NOPAT
1,946,000
2,131,000
6,344,000
Net income
1,845,000
-19.08%
2,280,000
-57.49%
5,364,000
81.28%
Dividends
(1,092,000)
(825,000)
(633,000)
Dividend yield
2.46%
2.55%
1.92%
Proceeds from repurchase of equity
(1,396,000)
(883,000)
BB yield
4.31%
2.68%
Debt
Debt current
2,978,000
2,852,000
3,414,000
Long-term debt
2,098,000
1,243,000
2,151,000
Deferred revenue
Other long-term liabilities
3,279,000
2,347,000
2,065,000
Net debt
(14,168,000)
(14,515,000)
(13,973,000)
Cash flow
Cash from operating activities
6,542,000
5,634,000
5,403,000
CAPEX
(5,859,000)
(4,588,000)
(2,720,000)
Cash from investing activities
(5,831,000)
(3,281,000)
(5,674,000)
Cash from financing activities
(141,000)
(3,717,000)
94,000
FCF
(368,000)
2,014,000
6,375,000
Balance
Cash
16,225,000
15,097,000
15,895,000
Long term investments
3,019,000
3,513,000
3,643,000
Excess cash
17,721,700
16,840,900
17,673,200
Stockholders' equity
38,660,000
37,357,000
35,575,000
Invested Capital
34,984,300
32,204,100
31,164,800
ROIC
5.79%
6.73%
20.22%
ROCE
5.17%
7.16%
16.70%
EV
Common stock shares outstanding
12,024
12,260
12,683
Price
3,690.00
39.72%
2,641.00
1.73%
2,596.00
-18.62%
Market cap
44,368,560
37.03%
32,378,660
-1.66%
32,925,068
-19.53%
EV
30,440,560
18,101,660
19,460,068
EBITDA
5,491,000
6,107,000
10,871,000
EV/EBITDA
5.54
2.96
1.79
Interest
30,000
32,000
35,000
Interest/NOPBT
1.10%
0.91%
0.43%